IMMUCELL CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.14 USD | +0.78% |
|
+2.39% | +0.98% |
| 09/04 | Immucell Corporation Reports Unaudited Sales Results for the Three Months and Twelve Months Ended March 31, 2024 | CI |
| 02/04 | ImmuCell Shares Fall After $20 Million Mixed Securities Shelf Filing | MT |
Chart calendar ImmuCell Corporation
8.oLEXWm2ZIJOt8_SS-uE7JOiSya32RgzYxHBB_HJJVsI.kNpnFl3eVfqUi9n9wtRed4al_-6xfmiRi0ULuyIhYKr3-lEuK6lspp7Chw~e66cf76bdb24705dc379dedc65188b26
Upcoming events on ImmuCell Corporation
Past events on ImmuCell Corporation
| 10/04/2024 01:35 am | Q1 2024 Sales and Revenue Release |
| 28/02/2024 07:30 pm | Q4 2023 Earnings Call |
| 28/02/2024 02:35 am | Q4 2023 Earnings Release |
| 01/02/2024 | Lytham Partners Investor Select Conference |
| 09/01/2024 02:35 am | Q4 2023 Sales and Revenue Release |
| 14/11/2023 07:30 pm | Q3 2023 Earnings Call |
| 14/11/2023 02:35 am | Q3 2023 Earnings Release |
| 06/10/2023 01:35 am | Q3 2023 Sales and Revenue Release |
| 11/08/2023 06:30 pm | Q2 2023 Earnings Call |
| 11/08/2023 01:35 am | Q2 2023 Earnings Release |
| 12/07/2023 01:35 am | Q2 2023 Sales and Revenue Release |
| 15/06/2023 06:30 pm | Annual General Meeting |
| 12/05/2023 06:30 pm | Q1 2023 Earnings Call |
| 12/05/2023 01:35 am | Q1 2023 Earnings Release |
| 06/04/2023 01:35 am | Q1 2023 Sales and Revenue Release |
| 22/02/2023 07:30 pm | FY 2022 Earnings Call |
| 22/02/2023 02:35 am | FY 2022 Earnings Release |
| 10/01/2023 02:35 am | FY 2022 Sales and Revenue Release |
| 22/11/2022 07:30 pm | Q3 2022 Earnings Call |
| 22/11/2022 02:35 am | Q3 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13,7 | 15,3 15,1 1.33% |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -1,38 -1,36 -1.55% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -1,03 -1,77 41.6% |
|
Net income Million USD | Released Forecast Spread | 0,00 | -1,02 -1,75 41.7% |
|
EPS USD | Released Forecast Spread | -0,19 | -0,14 -0,24 41.67% |
| Announcement Date | 18/02/20 | 22/02/21 |
More events
Past sector events for ImmuCell Corporation
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
- Stock Market
- Equities
- ICCC Stock
- Calendar ImmuCell Corporation
